Clinical Trials Browser

Recruiting × Trifluridine × 30 days × Clear all

NCT04920032 2026-04-13

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

Phase 1 Recruiting

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT05927857 2026-04-09

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Phase 1/2 Recruiting

Gastrointestinal

Metastatic Gastric Adenocarcinoma